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Objectives: to investigate the prevalence of risk factors in patients with premature atherosclerosis.
Design: retrospective controlled study.
Materials: 135 consecutive patients with premature atherosclerosis Z55 years (group I) were investigated. A control
group comprised 107 consecutive patients [65 years (group II) with atherosclerosis. Statistical analysis was performed
with Chi-squared test and logistic regression analysis.
Results: group I versus group II: diabetes 11% vs. 27% (p=0.001), smoking 84% vs. 67% (p=0.002), hypertension
36% vs. 58% (p=0.001), hypercholesterolaemia 47% vs. 34% (p=0.04), family history of cardiovascular disease 53%
vs. 42% (p=0.08). In group I hyperhomocysteinaemia was present in 24 of the 108 patients tested, anticardiolipin
antibodies were present in four of the 34 tested and coagulation abnormalities were found in four of the 22 patients
tested.
Conclusion: the difference in the prevalence of the different risk factors between the two groups suggests that either
certain risk factors are more likely to cause premature atherosclerosis, or that other risk factors must be present in addition
to the known risk factors in order to induce premature atherosclerosis.
Introduction I), undergoing angiography for arterial occlusive dis-
ease, during the period from January 1993 until
Only 1 to 7% of the patient population with athero- December 1996. A control group consisted of 107
sclerosis are young adults, depending on the age limit consecutive patients of 65 years and older (group II),
used to determine premature atherosclerosis. Pre- also admitted during the same period for angiography
mature atherosclerosis tends to follow a more virulent for atherosclerosis. In the control group the first symp-
course than atherosclerosis in the elderly.2,3 This leads toms of atherosclerosis had not occurred before the
us to believe that there must be risk factors other than age of 60 years. We excluded patients between the age
the common known cardiovascular risk factors which of 56 years and 64 years to avoid age overlap, so that
induce premature atherosclerosis. Recently the pres- the assessment of the different risk factors compared
ence of a hypercoagulable state, due to anticoagulant with age would be more meaningful. Patients with
deficiencies or to antiphospholipid antibodies, has aneurysmal disease, trauma or other non-
been identified as a risk factor for atherosclerosis, as atherosclerotic disease, e.g. arteritis, were excluded
well as hyperhomocysteinaemia. from the study.
The purpose of this study was to investigate the The angiograms of the patients of both groups were
prevalence of risk factors in patients with premature reviewed and the extent and distribution of athero-
atherosclerosis compared to elderly patients with sclerotic lesions were noted. The distribution of the
atherosclerosis. lesions were categorised as aortoiliac, femoropopliteal,
crural or multi-level when more than one region was
afflicted. Carotid lesions and lesions in the intestinal
and renal arteries and upper limb were also reviewed.Methods
The medical records were examined for medical his-
tory, age at onset of ischaemic symptoms and riskA retrospective review was performed of 135 con-
factors for cardiovascular disease. The risk factorssecutive patients of 55 years of age and younger (group
evaluated were: smoking, hypertension, diabetes,
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Table 1. Univariate and multivariate analysis of risk factors for atherosclerosis in patients with premature
atherosclerosis (Z55 years of age) and elderly patients with atherosclerosis ([65 years of age)
Risk factors Z55 years [65 years p-value Odds ratio 95% confidence
interval
Diabetes 11% 27% 0.001 0.44 0.21–0.93
Hypertension 36% 58% 0.001 0.41 0.23–0.71
Smoking 84% 67% 0.002 2.39 1.24–4.62
Hypercholesterolaemia 47% 35% 0.004 1.94 1.11–3.41
Family history 53% 42% 0.008 n.s. 0.87 0.44–1.71
Statistical analysis was performed by the Chi-squared test, p<0.05 was considered statistically significant.
was considered present if a patient was receiving in both groups is shown in Table 2. Significantly more
treatment for this condition. Furthermore, hyper- patients in the older group were admitted for stenotic
lipidaemia was considered present if the fasting level lesions of the cerebrovascular arteries (32% vs. 8%
of cholesterol was >6.5mmol/l or HDL <0.9 mmol/ p<0.0001). When the younger and elderly patients with
l or triglycerine >2.0 mmol/l or LDL >5.0 mmol/l, arterial lesions in the lower extremities were compared,
diabetes was considered present if two fasting venous the presence of the different risk factors did not differ
plasma glucose levels were >7.8mmol/l and hyper- from the percentages shown in Table 1. Significantly
tension was considered present when the diastolic more younger patients had only lesions at the aortoiliac
blood pressure was >105mmHg on more than three level (20% vs. 6% p<0.01). Even so, 67% of them had
occasions. The family history for cardiovascular dis- multi-level disease compared to 94% of the elderly.
eases was considered positive if one or more first Since 1994 a methionine loading test has been regu-
degree relatives were also afflicted. If patients with larly performed. In 24 (22%) of the 108 patients with
premature atherosclerosis were evaluated for the pres- premature atherosclerosis the test was positive, in-
ence of hyperhomocysteinaemia, antiphospholipid dicating the presence of hyperhomocysteinaemia. Hy-
antibodies or a hypercoagulable state, the results of perhomocysteinaemia was more often associated with
these tests were also noted. hyperlipidaemia (p=0.07) and with hypertension (p=
0.09), although this did not reach statistical significance
(Fisher exact test). In 1996 testing of the presence of
anticardiolipin antibodies in patients with premature
atherosclerosis was introduced. In total, 34 patients
Statistical analysis with premature atherosclerosis were tested, in four
patients (12%) either IgG or IgM antibodies wereStatistical analysis was performed by Pearson Chi-
present. Two patients were male and two female. Onlysquared test. The Fisher exact test was applied where
one patient (female) did not have a history of smoking.appropriate. Combinations of parameters were tested
Two of the four patients had a positive family historyby logistic regression analysis. The odds ratios with
of cardiovascular diseases. The atherosclerotic lesion95% confidence intervals were calculated. A p-value
was located in the upper extremity in two patientsof <0.05 was considered statistically significant.
and in the cerebrovascular arteries in one. The fourth
patient had an ulcer in the abdominal aorta with
stenosis of the coeliac artery and the superior mes-
enteric artery.
Since 1996 testing for clotting abnormalities wasResults
performed; the presence of deficiencies of protein C,
protein S and antithrombin III and resistance to ac-The mean age of the 135 younger patients (group I) was
tivated protein C (APC resistance) were evaluated.46.2 years with a mean age of onset of atherosclerotic
Twenty-two patients, in whom a thrombotic com-symptoms of 43.1 years. The mean age of the older
ponent was suspected, were tested. In total a hyper-patients (group II) was 72.6 years, with a mean age of
coagulable state was found in four (18%) of the 22onset of 69.3 years. Table 1 shows the presence of the
patients tested. One patient had protein S deficiency,different risk factors in group I and group II. In both
a non-smoking male who presented with digital ul-groups an average of 2.3 risk factors per patient was
present. The distribution of the atherosclerotic lesions ceration on his left hand due to occlusion of the ulnar
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Table 2. Distribution of the arterial lesions, stenosis greater than 50%.
Location Group I (Z55 yrs) Group II ([65 yrs) p-value
Aortoiliac 22 (16%) 4 (3.7%) <0.01
Femoropopliteal 7 (5%) 0
Crural 8 (6%) 0
Multi-level 74 (55%) 65 (60.7%) <0.001
Intestinal 3 (2%) 1 (1%)
Carotid 12 (9%) 35 (30.7%) <0.0001
Proximal extremity 9 (7%) 2 (2%)
Statistical analysis is performed by Chi-squared test. For comparison of the patients
with multi-level disease, only patients with peripheral vascular disease were taken into
consideration.
artery. There were three patients with APC resistance; sulphydryl group of homocystein, which facilitates the
in all three patients the lesions were located in the formation of hydrogen peroxide, which in its turn
lower extremities. No patients had antithrombin III facilitates the uptake of low-density lipoprotein by
deficiency or protein C deficiency. None of the patients smooth muscle cells.5,15,29,30 In our study 22% of the
with a hypercoagulable state had a history of venous tested patients had hyperhomocysteinaemia. This is
thrombosis. Three of the four patients had a positive consistent with the 30% which is noted by Griend et
family history of cardiovascular disease. al.15 and the 23% noted by van de Berg et al.31
An incidence of 30–90% of hypercoagulable states
has been reported in patients with premature athero-
sclerosis, depending on which tests were per-
Discussion formed.2,12–14 It is unlikely that the presence of a
hypercoagulable state in itself enhances the pro-In our study the common known risk factors for
gression of atherosclerosis, but one can imagine thatatherosclerosis were also present in the patients with
an arterial thrombosis is more readily formed in anpremature atherosclerosis. An equal number of risk
atherosclerotic artery, which leads a patient withfactors was present in patients with premature athero-
atherosclerosis and a hypercoagulable state to presentsclerosis and elderly patients with atherosclerosis. This
with symptoms at a younger age. In this study onlyis in contrast to what one might expect, that is that,
22 patients were tested for the existence of a hy-to develop premature atherosclerosis, more risk factors
percoagulable state, yet 4 (18%) had at least one posi-must be present. However, the prevalence of the dif-
tive test. Other studies have shown the mainferent risk factors was significantly different in the two
abnormalities to be deficiencies of protein S, C andgroups. Diabetes and hypertension were significantly
antithrombin III, resistance to activated protein C (APCmore common in the elderly population. This could
resistance), mainly due to a mutation in the factor Vbe expected, as the prevalence of both risk factors
gene, and the presence of anticardiolipin antibodies.increase with age. Patients with premature athero-
In our study, anticardiolipin antibodies were presentsclerosis tended to have a positive family history for
in 4 (12%) of the 34 patients tested. The prevalence ofcardiovascular disease. Smoking was significantly as-
all causes of hypercoagulability in a population withsociated with premature atherosclerosis. This might
premature atherosclerosis is four- to nine-fold higherbe a risk factor that has more effect than others on the
than in the general population.2,4,8,12,14 Deficiencies ofprogression of atherosclerosis. Our results are con-
certain coagulation factors in patients with prematuresistent with other studies in which smoking has been
atherosclerosis can be due to consumption of thesementioned as a major risk factor for premature athero-
factors, if the patients are tested in an acute phasesclerosis.1,3,14 However, this can not explain why 67%
of their disease. Only APC resistance has not beenof the elderly smoke, yet did not develop symptoms
associated with premature atherosclerosis. On the con-due to atherosclerosis at a younger age. Dyslipidaemia
trary, Ouriel et al. described the patient populationhas also been associated with the development of
with peripheral vascular disease and APC resistancepremature atherosclerosis10,11 and our results support
to be older than the patients without APC resistance,this. Dyslipidaemia can be exacerbated by smoking,11
although there was a higher incidence of graft failurewhich makes the combination of smoking and dys-
in patients with APC resistance.7 Eldrup et al.14 showedlipidaemia a significant risk factor for the early onset
47% of patients with peripheral vascular disease toof atherosclerosis. Homocysteinaemia causes athero-
sclerosis through damage to the vascular wall by the have hyperaggregable platelets, yet no incidence in the
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